QFITLIA Trademark

Trademark Overview

On Monday, July 19, 2021, a trademark application was filed for QFITLIA with the United States Patent and Trademark Office. The USPTO has given the QFITLIA trademark a serial number of 90836577. The federal status of this trademark filing is FIFTH EXTENSION - GRANTED as of Wednesday, October 23, 2024. This trademark is owned by Genzyme Corporation. The QFITLIA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of hemophilia
qfitlia

General Information

Serial Number90836577
Word MarkQFITLIA
Filing DateMonday, July 19, 2021
Status734 - FIFTH EXTENSION - GRANTED
Status DateWednesday, October 23, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 19, 2022

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of hemophilia

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, September 21, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGenzyme Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02141
Party NameGenzyme Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142

Trademark Events

Event DateEvent Description
Thursday, July 22, 2021NEW APPLICATION ENTERED
Tuesday, September 21, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, March 15, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, July 27, 2021TEAS VOLUNTARY AMENDMENT RECEIVED
Monday, October 4, 2021ASSIGNED TO LIE
Monday, October 4, 2021PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Monday, March 7, 2022ASSIGNED TO EXAMINER
Wednesday, March 30, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 19, 2022PUBLISHED FOR OPPOSITION
Tuesday, April 19, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 14, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 8, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, November 8, 2022SOU EXTENSION 1 FILED
Tuesday, November 8, 2022SOU EXTENSION 1 GRANTED
Thursday, November 10, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 8, 2023SOU TEAS EXTENSION RECEIVED
Monday, October 23, 2023SOU EXTENSION 3 FILED
Monday, October 23, 2023SOU EXTENSION 3 GRANTED
Wednesday, October 25, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 8, 2023SOU EXTENSION 2 FILED
Monday, May 8, 2023SOU EXTENSION 2 GRANTED
Wednesday, May 10, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 23, 2023SOU TEAS EXTENSION RECEIVED
Friday, May 3, 2024SOU TEAS EXTENSION RECEIVED
Friday, May 3, 2024SOU EXTENSION 4 FILED
Friday, May 3, 2024SOU EXTENSION 4 GRANTED
Saturday, May 4, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 23, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, October 23, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 23, 2024SOU EXTENSION 5 GRANTED
Wednesday, October 23, 2024SOU EXTENSION 5 FILED
Tuesday, April 15, 2025TEAS STATEMENT OF USE RECEIVED
Thursday, June 26, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, June 26, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, June 26, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, June 26, 2025TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

Related Keywords

qfitlia hemophilia treatment preparations pharmaceutical